Oligo Manufacturing Trends And Optimization
Source: Asahi Kasei Bioprocess
Scott Merz, Business Development Manager at Asahi Kasei Bioprocess America, provides his take on the recent oligonucleotide manufacturing market growth, key considerations for development, and common challenges that arise when scaling up equipment.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online
Asahi Kasei Bioprocess
This website uses cookies to ensure you get the best experience on our website. Learn more